| 0 (0%) | 03-15 18:41 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 17.53 | 1-year : | 20.47 |
| Resists | First : | 15.01 | Second : | 17.53 |
| Pivot price | 13.19 |
|||
| Supports | First : | 12.08 | Second : | 10.27 |
| MAs | MA(5) : | 14.18 |
MA(20) : | 12.79 |
| MA(100) : | 16.71  |
MA(250) : | 0 | |
| MACD | MACD : | 0.2 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 77.2 |
D(3) : | 76.7 |
| RSI | RSI(14): 60.7 |
|||
| 52-week | High : | 26.91 | Low : | 10.27 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ OMDA ] has closed below upper band by 17.4%. Bollinger Bands are 6.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 14.55 - 14.61 | 14.61 - 14.67 |
| Low: | 13.65 - 13.71 | 13.71 - 13.78 |
| Close: | 14.42 - 14.51 | 14.51 - 14.63 |
Sat, 14 Mar 2026
Omada Health (NASDAQ:OMDA) Rating Increased to Buy at Wall Street Zen - MarketBeat
Fri, 13 Mar 2026
Omada Health (NASDAQ:OMDA) Q4 2025 earnings call transcript - MSN
Fri, 13 Mar 2026
[144] Omada Health, Inc. SEC Filing - Stock Titan
Fri, 13 Mar 2026
OMDA Should I Buy - Intellectia AI
Thu, 12 Mar 2026
Omada Health (NASDAQ:OMDA) Price Target Lowered to $26.00 at JPMorgan Chase & Co. - MarketBeat
Thu, 12 Mar 2026
J.P. Morgan Initiates Omada Health(OMDA.US) With Buy Rating, Announces Target Price $26 - 富途牛牛
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 58 (M) |
| Shares Float | 43 (M) |
| Held by Insiders | 6.2 (%) |
| Held by Institutions | 87.9 (%) |
| Shares Short | 2,990 (K) |
| Shares Short P.Month | 1,500 (K) |
| EPS | -0.47 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 3.93 |
| Profit Margin | -5 % |
| Operating Margin | 4.3 % |
| Return on Assets (ttm) | -3.3 % |
| Return on Equity (ttm) | -8.7 % |
| Qtrly Rev. Growth | 58 % |
| Gross Profit (p.s.) | 2.95 |
| Sales Per Share | 4.49 |
| EBITDA (p.s.) | -0.12 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 18 (M) |
| Levered Free Cash Flow | 15 (M) |
| PE Ratio | -31.59 |
| PEG Ratio | 0 |
| Price to Book value | 3.69 |
| Price to Sales | 3.23 |
| Price to Cash Flow | 46.1 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|